Cytogenetic effects in human exposure to arsenic

Mutation Research - Reviews in Mutation Research

Volumn 386, Issue 3, 1997, Pages 219-228

  Gonsebatt, M E ^a   Vega, L ^a   Salazar, A M ^a   Montero, R ^a   Guzman P ^a   Blas, J ^a   Del Razo, L M ^b   Garcia Vargas G ^b   Albores, A ^b   Cebrian, M E ^b   Kelsh, M ^c   Ostrosky Wegman, P ^a  

^a INSTITUTO DE INVESTIGACIONES BIOMÉDICAS   (Mexico)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

^c NONE

Author keywords

Arsenic; Chromosomal aberrations; Exfoliated epithelial cells; Lymphocytes; Micronuclei

Indexed keywords

ARSENIC; CACODYLIC ACID; DRINKING WATER; METHANEARSONIC ACID;

ADULT; ARTICLE; CHROMATID ABERRATION; CHROMOSOME ABERRATION; CONTROLLED STUDY; CYTOGENETICS; ENVIRONMENTAL EXPOSURE; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MEXICO; MICRONUCLEUS; PRIORITY JOURNAL; SKIN MANIFESTATION;

ARIA;

EID: 0030851381     PISSN: 13835742     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5742(97)00009-4     Document Type: Review

References (33)

1. M.N. Bates, A.H. Smith, C. Hopenhayn-Rich, Arsenic ingestion and internal cancers, Am. J. Epidemiol. 135 (1992) 462-476.
2. ATSDR (Agency for Toxic Substances and Disease Registry) 1989 Toxicological Profile for Arsenic. U.S. Public Health Service, Atlanta, GA.
3. Nowel, P.C. (1991) Origins of human leukemia: An overview, in: J. Brugge, T. Curran, E. Harlow and F. McCormick (Eds.), Origins of Human Cancer, Cold Spring Harbor Laboratory Press, Plainview, NY, pp. 513-520.
4. Knudson, A. (1991), Genetics events in human carcinogenesis, in: J. Brugge, T. Curran, E. Harlow and F. McCormick (Eds.), Origins of Human Cancer, Cold Spring Harbor Laboratory Press, Plainview, NY, pp. 17-25.
5. D. Jacobson-Kram, D. Montalbano, The reproductive effects assessment group's report on the mutagenicity of inorganic arsenic, Environ. Mutagen. 7 (1985) 787-804.
6. T.C. Lee, R.Y. Huang, K.Y. Jan, Sodium arsenite enhances the cytotoxicity, clastogenicity and 6-thioguanine resistant mutagenicity of ultraviolet light in Chinese hamster ovary cells, Mutation Res. 148 (1985) 83-89.
7. D. Eastmond, J. Tucker, Identification of aneuploidy-inducing agents using cytokinesis-blocked human lymphocytes and an antikinetochore antibody, Environ. Mol. Mutagen. 13 (1989) 34-43.
8. A.N. Jha, M. Noditi, R. Nilsson, A.T. Natarajan, Genotoxic effects of sodium arsenite on human cells, Mutation Res. 248 (1992) 215-221.
9. L. Vega, M.E. Gonsebatt, P. Ostrosky-Wegman, Aneugenic effect of sodium arsenite on human lymphocytes in vitro: an individual susceptibility effect detected. Mutation Res. 334 (1995) 365-373.
10. EPA (1984) Environmental Protection Agency. Health Assessment Document for Inorganic Arsenic, final report. Research Triangle Park, NC. EPA 600/8-83-02IF.
11. IARC (1987) Monograph on the evaluation of carcinogenic risks to humans, International Agency for Research on Cancer, Lyon, Suppl. 6, 71-76.
12. D. Reali, F.D. Marino, S. Bahramandpour, A. Carducci, R. Barale, N. Loprieno, Micronuclei in exfoliated cells and urine mutagenicity in smokers, Mutation Res. 192 (1987) 145-149.
13. Rosin, M. (1989). Antigenotoxic activity of carotenoids in carcinogen-exposed populations, in: Y. Kuroda, D.M. Shankel and M.D. Waters (Eds.), Mechanisms of Antimutagenesis and Anticarcinogenesis, Plenum Press, New York, pp. 45-59.
14. F. Sarto, R. Tomanin, L. Giacomelli, A. Canova, F. Raimondi, C. Ghiotto, M.V. Florentine, Evaluation of chromosomal aberrations in lymphocytes and micronuclei in lymphocytes, oral mucosa and hair root cells of patients under antiblastic therapy, Mutation Res. 228 (1990) 157-169.
15. Cebrián, M.E., A. Albores, G. García-Vargas, L.M. Del Razo and P. Ostrosky-Wegman (1994) Chronic arsenic poisoning in humans: the case of Mexico, in: J.O. Niragu (Ed.), Arsenic in the Environment. Part II: Human and Ecosystem Effects, John Wiley & Sons, New York, pp. 93-107.
16. S. Yeh, Skin cancer in chronic arsenicism, Human Pathol. 4 (1973) 469-485.
17. P. Perry, S. Wolff, New Giemsa method for differential staining of sister chromatids, Nature 261 (1974) 156-161,
18. WHO (1985) Guidelines for the study of genetics effects in human populations. Env. Health Criteria, 46, Geneva.
19. P.E. Tolbert, C.M. Shy, J.W. Allen, Micronuclei and other nuclear anomalies in buccal smears: methods development, Mutation Res. 271 (1992) 69-77.
20. M. Vahter, B, Lind, Concentrations of arsenic in urine of the general population in Sweden, Sci. Tot. Env. 54 (1986) 1-12.
21. L.M. Del Razo, J.L. Hernández, G. García-Vargas, P. Ostrosky-Wegman, M.E. Gonsebatt, M.E. Cebrián, Urinary excretion of arsenic species in a human population chronically exposed to arsenic via drinking water. A pilot study, Environ. Geochem. Health 16 (1995) 91-100.
22. Lim, C.K. (1982) Some routine applications of high performance liquid chromatography in clinical chemistry, in: E. Kaiser, F. Gabl, M.M. Muler and M. Bayer (Eds.), XI International Congress of Clinical Chemistry, Walter de Gruyter and Co., Berlin, p. 957.
23. M.E. Gonsebatt, L. Vega, R. Montero, G. García-Vargas, L.M. Del Razo, A. Albores, M.E. Cebrián, P. Ostrosky-Wegman, Lymphocyte replicating ability in individuals exposed to arsenic via drinking water, Mutation Res. 313 (1994) 293-299.
24. I. Nordenson, G. Beckman, Occupational and environmental risks in and around a smelter in northern Sweden, Hereditas 88 (1978) 47-50.
25. K. Al-Sabti, D.D. Lloyd, A.A. Edwards, P. Stegnar, A survey of lymphocyte chromosomal damage in Slovenian workers exposed to occupational clastogens, Mutation Res. 280 (1992) 215-223.
26. M. Nakamuro, Y. Sayato, Comparative studies of chromosomal aberrations and induced by trivalent and pentavalent arsenic, Mutation Res. 88 (1981) 73-80.
27. Y.-M. Hsueh, G.-S. Cheng, M.-M. Wu, H.-S. Yu, T.-L. Kuo, C.-J. Chen, Multiple risk factors associated with arsenic-induced skin cancers: effects of chronic liver disease and malnutritional status, Br. J. Cancer 71 (1995) 109-114.
28. J.K. Wiencke, J.W. Yager, Specificity of arsenite in potentiating cytogenetic damage induced by the DNA crosslinking agent diepoxybutane, Environ. Mol. Mutagen. 19 (1992) 195-200.
29. H. Stich, R. San, M. Rosin, Adaptation of the DNA-repair and micronucleous tests to human cell suspensions and exfoliated cells, Ann. NY Acad, Sci. 407 (1983) 93-105.
30. C.-J. Chen, C.W. Chen, M.-M. Wu, T.-L. Kuo, Cancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic in drinking water, Br. J. Cancer 66 (1992) 888-892.
31. P. Ostrosky-Wegman, M.E. Gonsebatt, R. Montero, L. Vega, H. Barba, J. Espinosa, A. Palao, C. Cortinas, G. Garcia-Vargas, L.M. Del Razo, M. Cebrian, Lymphocyte proliferation kinetics and genotoxic findings in a pilot study on individuals chronically exposed to arsenic in Mexico, Mutation Res. 250 (1991) 477-482.
32. L. Hagmar, A. Brogger, I.-L. Hansteen, S. Heim, B. Högstedt, L. Knudsen, B. Lambert, K. Linnainmaa, F. Mitelman, I. Nordenson, C. Reuterwall, S. Salomaa, S. Skerfving, M. Sorsa, Cancer risk in humans predicted by increased levels of chromosomal aberrations in lymphocytes: Nordic Study Group on the Health Risk of Chromosome Damage, Cancer Res. 54 (1994) 1919-1922.
33. S. Bonassi, A. Abbondandolo, L. Camurri, L. Dal-Pra, M. De-Ferrari, F. Degrassi, A. Forni, L. Lamberti, C. Lando, P. Padovani, Are chromosome aberrations in circulating lymphocytes predictive of future cancer onset in humans? Preliminary results of an Italian cohort study, Cancer Genet. Cytogenet. 79 (2) (1995) 133-135.